Topical interferon-alpha2b and keloid treatment: a place for pretreatment?
Uysal
A Cagri
AC
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000287:Administration, Topical; D000328:Adult; D000634:Aminoquinolines / Q000008:administration & dosage / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004431:Ear, External; D005260:Female; D006801:Humans; D000077271:Imiquimod; D007369:Interferon Inducers / Q000627:therapeutic use*; D007627:Keloid / Q000188:drug therapy* / Q000601:surgery; D008297:Male; D010865:Pilot Projects
D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D007369:Interferon Inducers; D000077271:Imiquimod